Literature DB >> 1805566

A purified saponin acts as an adjuvant for a T-independent antigen.

A C White1, P Cloutier, R T Coughlin.   

Abstract

Three strains of mice were injected with a T-independent antigen, Escherichia coli 055:B5 polysaccharide (PS) combined with purified saponin, QS-21, isolated from Quillaja saponaria bank. PS was prepared by hydrolysis of lipopolysaccharide (LPS). Nine week old mice were injected intradermally with 60 micrograms PS, as determined by an anthrone assay, with or without 15 micrograms QS-21 on days 0 and 14. On day 22 sera were assayed by EIA for PS specific antibodies. Titers were 11-fold higher in CD-1 mice with QS-21. C3H/HeJ (Ipsd) and C3H/HeSnJ (Ipsr) mice also showed an adjuvant associated increase in titer with saponin. Therefore, LPS responsiveness was not required for the adjuvant effect. PS vaccinated C3H and CD-1 mice with and without QS-21 had similar antibody isotype profiles. IgG2b titers accounted for more than half of the total Ig response. IgG2a was next highest followed by IgG3, IgM, IgG1, and IgA. In comparison, CD-1 mice injected with 0.1 microgram intact LPS had a different LPS specific isotype profile. IgG3 was the highest followed by IgG1, IgG2b, IgM, IgG2a, and IgA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805566     DOI: 10.1007/978-1-4684-6000-1_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants.

Authors:  A A McCormick; M H Kumagai; K Hanley; T H Turpen; I Hakim; L K Grill; D Tusé; S Levy; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  Uncovering potential 'herbal probiotics' in Juzen-taiho-to through the study of associated bacterial populations.

Authors:  Diego Montenegro; Kriti Kalpana; Christine Chrissian; Ashutosh Sharma; Anna Takaoka; Maria Iacovidou; Clifford E Soll; Olga Aminova; Adriana Heguy; Lisa Cohen; Steven Shen; Akira Kawamura
Journal:  Bioorg Med Chem Lett       Date:  2014-12-19       Impact factor: 2.823

Review 3.  Molecular adjuvants and immunomodulators: new approaches to immunization.

Authors:  A G Johnson
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

Review 4.  Pre-erythrocytic malaria vaccines: identifying the targets.

Authors:  Patrick E Duffy; Tejram Sahu; Adovi Akue; Neta Milman; Charles Anderson
Journal:  Expert Rev Vaccines       Date:  2012-10       Impact factor: 5.217

Review 5.  Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers.

Authors:  Todd E Golde
Journal:  Neurotherapeutics       Date:  2022-02-28       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.